Share Cancellation
Hanmi Science will retire 448,286 common treasury shares, valued at KRW 9,363,585,341 on a book basis, on November 2, 2026.
Hanmi Science Co.,Ltd Disclosures
008930 · KOSPI · Based on DART filings
Disclosures
3 total · 20 per page
Major
20261027800677
Hanmi Science's Q3 2026 consolidated revenue was KRW 362.9 billion, up 5.9% year over year and down 1.4% quarter over quarter; operating profit was KRW 19.2 billion, down 51.3% and 67.6%.}
Share Cancellation
Hanmi Pharmaceutical, a subsidiary of Hanmi Science, decided to retire 85,316 common treasury shares, with a book value of KRW 28.3 billion, on November 2, 2026.
Catch the next disclosure fast
Get app alerts for new disclosures from Hanmi Science Co.,Ltd.